Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: A new use of silicon bioisosteres in medicinal chemistry

被引：63

作者：

Barnes, Matthew J. ^{[1
]}

Conroy, Richard ^{[1
]}

Miller, David J. ^{[1
]}

Mills, John S. ^{[1
]}

Montana, John G. ^{[1
]}

Pooni, Parminder K. ^{[1
]}

Showell, Graham A. ^{[1
]}

Walsh, Louise M. ^{[1
]}

Warneck, Julie B. H. ^{[1
]}

机构：

[1] Paradigm Therapeut Ltd, Cambridge CB4 0PA, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 02期

关键词：

silicon bioisostere; p38 MAP kinase;

D O I：

10.1016/j.bmcl.2006.10.044

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：354 / 357

页数：4

共 14 条

[1]

Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453

[2]

Bains W, 2003, CURR OPIN DRUG DISC, V6, P526

[3] ORGANOSILICON COMPOUNDS .50. SELECTIVE SUBSTITUTIONS IN C-SILYLPYRAZOLES [J].

BIRKOFER, L ;

FRANZ, M .

CHEMISCHE BERICHTE-RECUEIL, 1972, 105 (05) :1759-&

[4] Identification of novel p38α MAP kinase inhibitors using fragment-based lead generation [J].

Gill, AL ;

Frederickson, M ;

Cleasby, A ;

Woodhead, SJ ;

Carr, MG ;

Woodhead, AJ ;

Walker, MT ;

Congreve, MS ;

Devine, LA ;

Tisi, D ;

O'Reilly, M ;

Seavers, LCA ;

Davis, DJ ;

Curry, J ;

Anthony, R ;

Padova, A ;

Murray, CW ;

Carr, RAE ;

Jhoti, H .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :414-426

[5]

Kumar S, 2005, HANDB EXP PHARMACOL, V167, P65

[6] New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid cupric acetate arylation [J].

Lam, PYS ;

Clark, CG ;

Saubern, S ;

Adams, J ;

Winters, MP ;

Chan, DMT ;

Combs, A .

TETRAHEDRON LETTERS, 1998, 39 (19) :2941-2944

[7] Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase [J].

Liverton, NJ ;

Butcher, JW ;

Claiborne, CF ;

Claremon, DA ;

Libby, BE ;

Nguyen, KT ;

Pitzenberger, SM ;

Selnick, HG ;

Smith, GR ;

Tebben, A ;

Vacca, JP ;

Varga, SL ;

Agarwal, L ;

Dancheck, K ;

Forsyth, AJ ;

Fletcher, DS ;

Frantz, B ;

Hanlon, WA ;

Harper, CF ;

Hofsess, SJ ;

Kostura, M ;

Lin, J ;

Luell, S ;

O'Neill, EA ;

Orevillo, CJ ;

Pang, M ;

Parsons, J ;

Rolando, A ;

Sahly, Y ;

Visco, DM ;

O'Keefe, SJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) :2180-2190

[8] p38 MAP kinase: a convergence point in cancer therapy [J].

Olson, JM ;

Hallahan, AR .

TRENDS IN MOLECULAR MEDICINE, 2004, 10 (03) :125-129

[9]

Pargellis Christopher, 2003, Curr Opin Investig Drugs, V4, P566

[10] Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate [J].

Regan, J ;

Breitfelder, S ;

Cirillo, P ;

Gilmore, T ;

Graham, AG ;

Hickey, E ;

Klaus, B ;

Madwed, J ;

Moriak, M ;

Moss, N ;

Pargellis, C ;

Pav, S ;

Proto, A ;

Swinamer, A ;

Tong, L ;

Torcellini, C .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :2994-3008

← 1 2 →